## Pathophysiology of RDS **Key Point:** RDS (Hyaline Membrane Disease) is caused by surfactant deficiency in preterm infants, leading to increased alveolar surface tension, alveolar collapse, and impaired gas exchange. ## Surfactant Deficiency Mechanism 1. Surfactant production begins around 24 weeks gestation 2. Adequate surfactant levels are typically achieved by 34–35 weeks 3. Deficiency causes: - Increased alveolar surface tension (LaPlace's Law) - Widespread atelectasis - Ventilation-perfusion mismatch - Hypoxemia and hypercarbia ## Antenatal Corticosteroid Therapy **High-Yield:** Maternal corticosteroids (betamethasone or dexamethasone) given between 24–34 weeks gestation accelerate fetal lung maturity by: - Inducing surfactant synthesis - Reducing RDS incidence by ~50% - Decreasing intraventricular hemorrhage and neonatal mortality [cite:Harrison 21e Ch 180] ## Exogenous Surfactant Replacement **Clinical Pearl:** Modern practice favors **early surfactant replacement** (within the first 1–2 hours of life or even in the delivery room for very preterm infants) rather than waiting for severe hypoxemia. Early treatment: - Reduces need for mechanical ventilation - Decreases air leak syndromes (pneumothorax, pulmonary interstitial emphysema) - Improves oxygenation and ventilation more rapidly - Reduces mortality and chronic lung disease (CLD) **Warning:** Withholding surfactant until severe hypoxemia develops is outdated and harmful — it increases barotrauma, volutrauma, and oxygen toxicity. ## Mechanical Ventilation and PEEP **Key Point:** PEEP (typically 4–6 cm H~2~O) is essential in RDS management because it: - Recruits and maintains alveolar patency - Reduces repetitive opening-closing injury (atelectotrauma) - Improves oxygenation and lung compliance - Is a cornerstone of lung-protective ventilation strategies ## Summary Table: RDS Management Principles | Intervention | Timing | Rationale | | --- | --- | --- | | Antenatal corticosteroids | 24–34 weeks gestation | Accelerate surfactant synthesis | | Exogenous surfactant | Early (1–2 hrs or delivery room) | Reduce ventilation requirement, air leak, mortality | | PEEP | Initiation of ventilation | Maintain alveolar recruitment, reduce atelectotrauma | | Gentle ventilation | Ongoing | Minimize barotrauma and volutrauma | **The INCORRECT statement** is that surfactant should be withheld until severe hypoxemia develops — this is contraindicated in modern neonatal practice.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.